These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12630609)

  • 1. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass.
    Moize V; Geliebter A; Gluck ME; Yahav E; Lorence M; Colarusso T; Drake V; Flancbaum L
    Obes Surg; 2003 Feb; 13(1):23-8. PubMed ID: 12630609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of varying levels of protein intake on protein status indicators after gastric bypass in patients with multiple complications requiring nutritional support.
    Rinaldi Schinkel E; Pettine SM; Adams E; Harris M
    Obes Surg; 2006 Jan; 16(1):24-30. PubMed ID: 16417753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population.
    Kalfarentzos F; Skroubis G; Kehagias I; Mead N; Vagenas K
    Obes Surg; 2006 Feb; 16(2):151-8. PubMed ID: 16469216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc nutritional status of morbidly obese patients before and after Roux-en-Y gastric bypass: a preliminary report.
    Cominetti C; Garrido AB; Cozzolino SM
    Obes Surg; 2006 Apr; 16(4):448-53. PubMed ID: 16608609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catabolic effects of gastric bypass in a diet-induced obese rat model.
    Guijarro A; Kirchner H; Meguid MM
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):423-35. PubMed ID: 16778572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Magenstrasse and Mill procedure can be combined with a Roux-en-Y gastric bypass to produce greater and sustained weight loss.
    Robinson J; Sue-Ling H; Johnston D
    Obes Surg; 2006 Jul; 16(7):891-6. PubMed ID: 16839489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.
    Stratis C; Alexandrides T; Vagenas K; Kalfarentzos F
    Obes Surg; 2006 Jun; 16(6):752-8. PubMed ID: 16756737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass.
    Gómez-Ambrosi J; Salvador J; Rotellar F; Silva C; Catalán V; Rodríguez A; Jesús Gil M; Frühbeck G
    Obes Surg; 2006 Mar; 16(3):262-9. PubMed ID: 16545156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies.
    Skroubis G; Anesidis S; Kehagias I; Mead N; Vagenas K; Kalfarentzos F
    Obes Surg; 2006 Apr; 16(4):488-95. PubMed ID: 16608616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight changes in spouses of gastric bypass patients.
    Madan AK; Turman KA; Tichansky DS
    Obes Surg; 2005 Feb; 15(2):191-4. PubMed ID: 15802060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up.
    Cottam DR; Atkinson J; Anderson A; Grace B; Fisher B
    Obes Surg; 2006 May; 16(5):534-40. PubMed ID: 16687018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass.
    Ortega J; Escudero MD; Mora F; Sala C; Flor B; Martinez-Valls J; Sanchiz V; Martinez-Alzamora N; Benages A; Lledo S
    Obes Surg; 2004 Sep; 14(8):1086-94. PubMed ID: 15479598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass.
    El-Kadre LJ; Rocha PR; de Almeida Tinoco AC; Tinoco RC
    Obes Surg; 2004 Sep; 14(8):1062-6. PubMed ID: 15479594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic conversion of laparoscopic gastric banding to Roux-en-Y gastric bypass: a review of 70 patients.
    Mognol P; Chosidow D; Marmuse JP
    Obes Surg; 2004; 14(10):1349-53. PubMed ID: 15603650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia.
    Frühbeck G; Rotellar F; Hernández-Lizoain JL; Gil MJ; Gómez-Ambrosi J; Salvador J; Cienfuegos JA
    Obes Surg; 2004 Oct; 14(9):1208-15. PubMed ID: 15527636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessment.
    Houghton SG; Nelson LG; Swain JM; Nesset EM; Kendrick ML; Thompson GB; Murr MM; Nichols FC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):475-80. PubMed ID: 16925273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
    Gould JC; Garren MJ; Boll V; Starling JR
    Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery.
    Engström BE; Ohrvall M; Sundbom M; Lind L; Karlsson FA
    Int J Obes (Lond); 2007 Mar; 31(3):476-80. PubMed ID: 16924271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.